AMETEK (AME) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
30 Jun, 2026Executive summary
Achieved record Q4 and full-year results for sales, operating income, EBITDA, EPS, and cash flow, despite a challenging macroeconomic environment.
Q4 sales reached $1.76B, up 2% year-over-year, with organic sales down 3% but acquisitions adding 5 points.
Full-year 2024 sales reached $6.94B, a 5% increase over 2023, with record operating cash flow of $1.83B, up 5%.
Adjusted EPS for Q4 was $1.87, up 11% year-over-year; full-year adjusted EPS was $6.83, up 7%.
Repurchased $155M in shares in Q4 and $220M for the year; announced acquisition of Kern Microteknik for €105M.
Financial highlights
Q4 operating income: $469M, up 5% year-over-year; operating margin 26.6%, up 90 bps.
Q4 EBITDA: $561M, up 7% year-over-year; EBITDA margin 31.9%.
Q4 free cash flow: $498M, up 4%; free cash flow to net income conversion 129%.
Q4 diluted EPS: $1.87, up 11%, exceeding guidance.
Full-year 2024 sales: $6.94B, up 5%; operating income: $1.81B, up 6%; EBITDA: $2.18B, up 8%.
Full-year EPS: $6.83, up 7%; free cash flow: $1.7B, up 6%, with 124% conversion.
Q4 GAAP EPS was $1.67; adjusted EPS excludes $0.20 per share of non-cash, after-tax, acquisition-related amortization.
Dividends per share increased to $0.28 in Q4 and $1.12 for the year.
Outlook and guidance
2025 sales expected to grow low single digits; EPS guidance $7.02–$7.18, up 3–5%.
Q1 2025 sales expected flat year-over-year; adjusted EPS $1.67–$1.69, up 2–3%.
Free cash flow conversion expected at ~115% for 2025.
Capital expenditures projected at $155M (2% of sales); depreciation and amortization at $400M.
Latest events from AMETEK
- All proposals passed, with record results and a major acquisition set for late 2026.AME
AGM 20267 May 2026 - $5B deal adds $1.1B sales, 10–12% synergies, and boosts recurring revenue in 2026.AME
M&A announcement6 May 2026 - Record Q1 growth, margin expansion, and raised outlook on strong demand and acquisitions.AME
Q1 202630 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and ESG.AME
Proxy Filing11 Mar 2026 - Proxy covers director elections, executive pay, and auditor ratification for shareholder vote.AME
Proxy Filing11 Mar 2026 - Record sales, profit, and cash flow set strong momentum for 2026 growth and robust demand.AME
Q4 20253 Feb 2026 - Record 2025 sales and EPS growth reflect strong execution, innovation, and strategic acquisitions.AME
Investor presentation3 Feb 2026 - Q2 sales and margins hit records, but 2024 outlook trimmed amid inventory and demand headwinds.AME
Q2 20242 Feb 2026 - Q3 sales up 5.3%, adjusted EPS up 1%, guidance raised, strong cash flow and acquisitions.AME
Q3 202417 Jan 2026